Literature DB >> 9372079

Potential clinical applications of interleukin-12.

C Chougnet1, G M Shearer.   

Abstract

Interleukin-12 is a central modulatory cytokine with potent effects on the development and differentiation of the cellular immune response. Because of its biologic activities, interleukin-12 could either mediate or contribute to the control of a large range of critical world-wide pathologic conditions, including infectious diseases and cancer. Its potential efficacy has been demonstrated in several animal models of intracellular pathogens and tumors, as well as in vitro in some human pathologies. As an adjuvant, interleukin-12 appears to be useful for inducing a protective immune response in different animal models. However, its potential toxicity and complex regulation indicate that clinical trials must proceed with caution. Thus its prophylactic and therapeutic value may reside in our ability to minimize toxicity and simultaneously deliver this cytokine to immunologically relevant sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9372079     DOI: 10.1097/00062752-199603030-00009

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  2 in total

1.  Interleukin-12-secreting fibroblasts are more efficient than free recombinant interleukin-12 in inducing the persistent resistance to Mycobacterium avium complex infection.

Authors:  B Y Kang; S W Chung; Y S Lim; E J Kim; S H Kim; S Y Hwang; T S Kim
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

2.  Efficient induction of an antigen-specific, T helper type 1 immune response by interleukin-12-secreting fibroblasts.

Authors:  T S Kim; K M Kim; B A Shin; S Y Hwang
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.